MTM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62525548574877E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.37529987398466E-10 |
Normal-vs-Stage2 |
2.78269999998138E-06 |
Normal-vs-Stage3 |
1.62525548574877E-12 |
Normal-vs-Stage4 |
1.62614366416847E-12 |
Stage1-vs-Stage2 |
3.175000E-01 |
Stage1-vs-Stage3 |
2.428700E-04 |
Stage1-vs-Stage4 |
3.52799999999709E-05 |
Stage2-vs-Stage3 |
1.474790E-01 |
Stage2-vs-Stage4 |
4.732200E-02 |
Stage3-vs-Stage4 |
4.314000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.66453525910038E-15 |
Normal-vs-AfricanAmerican |
4.50572912313874E-12 |
Normal-vs-Asian |
3.189800E-02 |
Caucasian-vs-AfricanAmerican |
1.562400E-01 |
Caucasian-vs-Asian |
4.700400E-01 |
AfricanAmerican-vs-Asian |
1.679230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
2.93419954999763E-10 |
Male-vs-Female |
2.224300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.81208389907306E-12 |
Normal-vs-Age(41-60Yrs) |
2.692290834716E-13 |
Normal-vs-Age(61-80Yrs) |
5.67323965583455E-14 |
Normal-vs-Age(81-100Yrs) |
8.11470000000591E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.923000E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.401400E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.478800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.117000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.423200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.437400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.040400E-02 |
Normal-vs-Grade 2 |
4.03480004962375E-09 |
Normal-vs-Grade 3 |
2.22044604925031E-16 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
5.448000E-01 |
Grade 1-vs-Grade 3 |
6.413900E-02 |
Grade 1-vs-Grade 4 |
7.773000E-04 |
Grade 2-vs-Grade 3 |
2.018400E-03 |
Grade 2-vs-Grade 4 |
1.12499999982418E-07 |
Grade 3-vs-Grade 4 |
8.380700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.7943999999992E-05 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
2.94119950616789E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.79078973872038E-12 |
Normal-vs-N1 |
1.845120E-04 |
N0-vs-N1 |
9.366200E-02 |
|
|